(Q45863771)

17 December 2017

title

Immunosuppressive effects of factor IX products: an in vitro study (English)

1 reference

17 December 2017

author

Wolfram Samlowski

3

1 reference

17 December 2017

author name string

Grosset AB

1

1 reference

17 December 2017

McGregor JR

2

1 reference

17 December 2017

Rodgers GM

4

1 reference

17 December 2017

publication date

1 November 1999

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

5

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

416-425

1 reference

17 December 2017

Blood transfusion and postoperative infections

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00343.X

Unusually high incidence of tuberculosis among boys with haemophilia during an outbreak of the disease in hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00343.X

Immunological studies in HIV seronegative haemophiliacs: relationships to blood product therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00343.X

Immunosuppressive property of a very high purity antihaemophilic preparation: a low molecular weight component inhibits an early step of PHA induced cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00343.X

Inhibition of lymphocyte IL2-receptor expression by factor VIII concentrate: a possible cause of immunosuppression in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00343.X

Mechanisms of inhibition of T cell IL-2 secretion by factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00343.X

T cell sensitization to factor VIII in haemophilia A?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00343.X

Capacity to produce interleukin 2 is impaired in haemophilia in the absence and presence of HIV 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00343.X

Functional studies of cell-mediated immunity in haemophilia and other bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00343.X

Phenotypic and functional abnormalities in monocytes from patients with haemophilia A treated with factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00343.X

Nitric oxide exposure inhibits induction of lymphokine-activated killer cells by inducing precursor apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00343.X

Why prescribe highly purified factor VIII and IX concentrates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00343.X

10.1046/J.1365-2516.1999.00343.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017